Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Forside
2330
River Eletec
6666
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.01%30.16B | 5.44%116.19B | 3.82%28.79B | 3.32%29.28B | 8.78%29.68B | 5.97%28.45B | 10.00%110.19B | 8.89%27.73B | 7.69%28.33B | 12.24%27.29B |
Cost of revenue | 1.96%13.63B | 6.69%55.18B | -0.07%13.62B | 5.26%13.89B | 13.93%14.31B | 8.33%13.37B | 9.36%51.72B | 13.80%13.63B | 3.60%13.2B | 11.75%12.56B |
Gross profit | 9.60%16.53B | 4.34%61.01B | 7.59%15.17B | 1.63%15.39B | 4.38%15.37B | 3.95%15.08B | 10.58%58.47B | 4.51%14.1B | 11.54%15.14B | 12.65%14.73B |
Operating expense | 11.11%13.85B | 12.17%52.06B | 8.91%13.75B | 14.78%13.11B | 12.85%12.74B | 12.49%12.46B | 8.13%46.41B | 9.08%12.63B | 7.83%11.42B | 6.81%11.29B |
Operating profit | 2.44%2.68B | -25.79%8.95B | -3.66%1.42B | -38.78%2.28B | -23.39%2.64B | -23.65%2.62B | 21.15%12.06B | -23.03%1.48B | 24.74%3.72B | 37.26%3.44B |
Net non-operating interest income (expenses) | 40.91%-130M | -46.04%-590M | -56.00%-117M | -53.01%-127M | -50.00%-126M | -35.80%-220M | -29.07%-404M | -25.00%-75M | 24.55%-83M | -16.67%-84M |
Non-operating interest income | 172.73%30M | 127.78%82M | 141.67%29M | 140.00%24M | 100.00%18M | 120.00%11M | 89.47%36M | 100.00%12M | 42.86%10M | 125.00%9M |
Non-operating interest expense | 23.08%160M | 58.17%571M | 67.82%146M | 62.37%151M | 54.84%144M | 47.73%130M | 8.73%361M | 31.82%87M | -20.51%93M | 22.37%93M |
Total other finance cost | ---- | 27.85%101M | --0 | --0 | --0 | 27.85%101M | --79M | --0 | --0 | --0 |
Net investment income | 306.56%126M | 0.98%-203M | -115.38%-280M | 56.67%141M | 97.54%-3M | -41.86%-61M | -3,516.67%-205M | -233.33%-130M | 592.31%90M | -190.48%-122M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -166.67%-8M | -10.53%-21M | 33.33%-6M | -500.00%-4M | -100.00%-8M | 57.14%-3M | -173.08%-19M | 62.50%-9M | -98.00%1M | -118.18%-4M |
Special income (charges) | -160.49%-49M | -371.49%-1.11B | -508.25%-1.18B | 73.53%-9M | 0 | 4,150.00%81M | -170.11%-235M | -288.00%-194M | -78.95%-34M | -66.67%-5M |
Less:Other special charges | 160.49%49M | -111.59%-27M | -76.56%45M | -73.53%9M | --0 | -4,150.00%-81M | 223.61%233M | 448.57%192M | 78.95%34M | 66.67%5M |
Less:Write off | ---- | 56,650.00%1.14B | ---- | ---- | ---- | ---- | -86.67%2M | ---- | ---- | ---- |
Other non-operating income (expenses) | 27.59%74M | -72.73%87M | -182.05%-64M | -67.03%30M | 6.78%63M | -36.26%58M | 3.24%319M | -19.59%78M | -11.65%91M | 11.32%59M |
Income before tax | 8.98%2.7B | -38.23%7.12B | -119.67%-226M | -38.93%2.31B | -22.09%2.56B | -25.15%2.47B | 16.34%11.52B | -37.69%1.15B | 25.42%3.78B | 32.98%3.29B |
Income tax | 3.80%929M | -37.82%2.57B | -130.16%-190M | -10.91%1.05B | -28.70%815M | -24.34%895M | 21.06%4.14B | -12.50%630M | 12.04%1.18B | 50.20%1.14B |
Net income | 11.98%1.77B | -38.47%4.54B | -107.12%-37M | -51.66%1.26B | -18.53%1.75B | -25.65%1.58B | 13.87%7.38B | -53.74%520M | 32.58%2.6B | 25.32%2.14B |
Net income continuous operations | 11.91%1.77B | -38.46%4.54B | -106.94%-36M | -51.68%1.26B | -18.57%1.75B | -25.60%1.58B | 13.85%7.38B | -53.83%519M | 32.64%2.6B | 25.32%2.14B |
Noncontrolling interests | 0 | 0.00%2M | 0 | 0.00%1M | 0.00%1M | 0 | 2M | 0 | 1M | 1M |
Net income attributable to the company | 11.92%1.77B | -38.48%4.54B | -107.32%-38M | -51.64%1.26B | -18.58%1.74B | -25.65%1.58B | 13.83%7.38B | -53.78%519M | 32.60%2.6B | 25.19%2.14B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 11.92%1.77B | -38.48%4.54B | -107.32%-38M | -51.64%1.26B | -18.58%1.74B | -25.65%1.58B | 13.83%7.38B | -53.78%519M | 32.60%2.6B | 25.19%2.14B |
Gross dividend payment | ||||||||||
Basic earnings per share | 11.71%23.18 | -38.66%59.65 | -107.49%-0.51 | -51.86%16.47 | -18.80%22.94 | -25.84%20.75 | 13.45%97.25 | -54.08%6.81 | 32.08%34.21 | 24.89%28.25 |
Diluted earnings per share | 11.52%21.39 | -38.55%55.17 | -108.06%-0.51 | -51.76%15.22 | -18.76%21.17 | -25.77%19.18 | 13.53%89.78 | -53.90%6.33 | 32.17%31.55 | 24.87%26.06 |
Dividend per share | 0 | 0.00%25 | 0.00%25 | 0 | 0 | 0 | 25.00%25 | 25.00%25 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |